Dr Diane Marie Hentz, MD | |
5750 Falls Dr, Fort Wayne, IN 46804-7147 | |
(260) 436-8000 | |
(260) 432-5587 |
Full Name | Dr Diane Marie Hentz |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 5750 Falls Dr, Fort Wayne, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235237074 | NPI | - | NPPES |
P00074720 | Other | MEDICARE RAILROAD | |
01038843B | Other | IN | CSR LICENSE NUMBER |
1390 | Other | PHP | |
000000308077 | Other | BCBS | |
4045038 | Other | AETNA | |
100359250 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 01038843A (Indiana) | Primary |
207NS0135X | Dermatology - Procedural Dermatology | 01038843A (Indiana) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Diane Marie Hentz, MD 5750 Falls Dr, Fort Wayne, IN 46804-7147 Ph: (260) 436-8000 | Dr Diane Marie Hentz, MD 5750 Falls Dr, Fort Wayne, IN 46804-7147 Ph: (260) 436-8000 |
News Archive
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 ("miR-103/107") for the treatment of Non Alcoholic Steatohepatitis ("NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies' strategic alliance to discover, develop and commercialize microRNA therapeutics.
Researchers from Dr. Woodland's lab at the Trudeau Institute have now identified a previously unknown link between the migration of white blood cells to infected tissues and the ability of these cells to survive and become long-lived memory cells after the infection has been cleared.
Novartis today announced data from the largest clinical trial of myelofibrosis patients treated with Jakavi (ruxolitinib), supporting the safety profile and efficacy benefit as measured in primary and secondary endpoints respectively.
When used with a transdermal nicotine patch, nortriptyline—an antidepressant medication—may aid in smoking cessation, according to an article in the November 8 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 3 days ago
Dr. Jennifer Lynn Hobbs, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5750 Falls Dr, Fort Wayne, IN 46804 Phone: 260-436-8000 Fax: 260-432-5587 | |
Patrick M. Veerkamp, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7881 Carnegie Blvd, Fort Wayne, IN 46804 Phone: 260-436-8000 Fax: 260-434-0929 | |
Dr. Alan R Gilbert, M. D. Dermatology Medicare: Medicare Enrolled Practice Location: 10620 Corporate Dr Ste A, Fort Wayne, IN 46845 Phone: 260-423-2567 Fax: 260-420-2415 | |
David A Grekin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4020 New Vision Dr, Fort Wayne, IN 46845 Phone: 260-423-2567 Fax: 260-420-2415 | |
Ms. Jacquelyn Ray Beemer, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5650 Coventry Ln, Fort Wayne, IN 46804 Phone: 260-436-9696 | |
Dr. James Richard Kyler, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5750 Falls Dr, Fort Wayne, IN 46804 Phone: 260-436-8000 Fax: 260-432-5587 |